価格表

在庫・価格 : 2024年04月25日 15時17分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-FOXC2, Mouse-Mono(2H3) <Anti-Forkhead Box C2>
データシート※最新のデータシートでない場合があります
H00002303-M02 ABNアブノヴァ
Abnova Corporation
100 μg ¥72,000
(未発注)
追加

在庫・価格 : 2024年04月25日 15時17分 現在

Anti-FOXC2, Mouse-Mono(2H3) <Anti-Forkhead Box C2>

  • 商品コード:H00002303-M02
  • メーカー:ABN
  • 包装:100μg
  • 価格: ¥72,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Nishida N et al. FOXC2 is a novel prognostic factor in human esophageal squamous cell carcinoma. Ann. Surg. Oncol. 2011 Feb;18(2):535-42
Nishida N et al
2011/01/01
PubMed
2 Yu YH et al. MiR-520h-mediated FOXC2 regulation is critical for inhibition of lung cancer progression by resveratrol. Oncogene 2012 Mar;
Yu YH et al
2012/01/01
PubMed
3 Imayama N et al. FOXC2 Expression is Associated with Tumor Proliferation and Invasion Potential in Oral Tongue Squamous Cell Carcinoma. Pathol. Oncol. Res. 2015 Jul;21(3):783-91
Imayama N et al
2015/01/01
PubMed
4 Shimoda Y et al. High expression of forkhead box protein C2 is associated with aggressive phenotypes and poor prognosis in clinical hepatocellular carcinoma. BMC Cancer 2018 May;18(1):597
Shimoda Y et al
2018/01/01
PubMed
5 B淡rretzen A et al. FOXC2 expression and epithelial-mesenchymal phenotypes are associated with castration resistance, metastasis and survival in prostate cancer. J Pathol Clin Res 2019 10;5(4):272-286
B淡rretzen A et al
2019/01/01
PubMed
  • No.: 1
  • 文献情報:
    Nishida N et al. FOXC2 is a novel prognostic factor in human esophageal squamous cell carcinoma. Ann. Surg. Oncol. 2011 Feb;18(2):535-42
    Nishida N et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Yu YH et al. MiR-520h-mediated FOXC2 regulation is critical for inhibition of lung cancer progression by resveratrol. Oncogene 2012 Mar;
    Yu YH et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Imayama N et al. FOXC2 Expression is Associated with Tumor Proliferation and Invasion Potential in Oral Tongue Squamous Cell Carcinoma. Pathol. Oncol. Res. 2015 Jul;21(3):783-91
    Imayama N et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Shimoda Y et al. High expression of forkhead box protein C2 is associated with aggressive phenotypes and poor prognosis in clinical hepatocellular carcinoma. BMC Cancer 2018 May;18(1):597
    Shimoda Y et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    B淡rretzen A et al. FOXC2 expression and epithelial-mesenchymal phenotypes are associated with castration resistance, metastasis and survival in prostate cancer. J Pathol Clin Res 2019 10;5(4):272-286
    B淡rretzen A et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed